SCHEMBL6026064

SCHEMBL6026064

NCCCCCCNC(=O)COC[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PRKACA P17612 7/20 0.67
▸ DNPH1 O43598 1/20 0.58
▸ PRKAB2 O43741 1/20 0.58
▸ TRPM2 O94759 1/20 0.58
▸ LDHA P00338 1/20 0.58
▸ ADRB2 P07550 1/20 0.58
▸ FBP1 P09467 1/20 0.58
▸ SRC P12931 1/20 0.58
▸ ADORA1 P30542 1/20 0.58
▸ P2RY2 P41231 1/20 0.58
▸ P2RY1 P47900 1/20 0.58
▸ PRKAG1 P54619 1/20 0.58
▸ PRKAA2 P54646 1/20 0.58
▸ PDE4D Q08499 1/20 0.58
▸ KCNH2 Q12809 1/20 0.58
▸ PRKAA1 Q13131 1/20 0.58
▸ PDE3A Q14432 1/20 0.58
▸ SMN1; SMN2 Q16637 1/20 0.58
▸ TAS1R3 Q7RTX0 1/20 0.58
▸ TAS1R1 Q7RTX1 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10886673 0.85 DOT1L (0.66) DNPH1PRKAB2TRPM2LDHAADRB2
SCHEMBL8388991 0.84 DOT1L (0.66) PRKACADNPH1PRKAB2TRPM2LDHA
SCHEMBL6026018 0.83 P2RY1 (0.70) DNPH1PRKAB2TRPM2LDHAADRB2
SCHEMBL6828798 0.81 ADORA1 (0.70) DNPH1PRKAB2TRPM2LDHAADRB2
SCHEMBL7642296 0.80 PRKACA (0.65) PRKACADNPH1PRKAB2TRPM2LDHA
SCHEMBL8007640 0.80 DOT1L (0.65) DNPH1PRKAB2TRPM2LDHAADRB2
SCHEMBL12450414 0.80 P2RY1 (0.72) DNPH1PRKAB2TRPM2LDHAADRB2
SCHEMBL8982622 0.80 ADORA3 (0.67) PRKACADNPH1PRKAB2TRPM2LDHA
SCHEMBL8328542 0.79 ADORA1 (0.74) DNPH1PRKAB2TRPM2LDHAADRB2
SCHEMBL2793634 0.79 ADORA1 (0.67) DNPH1PRKAB2TRPM2LDHAADRB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4108774-A1 ARTIFICIAL NUCLEIC ACID MOLECULES CureVac AG (DE) 2022-12-28 — — EP disclosed
EP-3341482-B1 ARTIFICIAL NUCLEIC ACID MOLECULES CUREVAC AG (DE) 2022-07-06 — — EP disclosed
US-20180237786-A1 ARTIFICIAL NUCLEIC ACID MOLECULES CUREVAC AG (DE) 2018-08-23 — — US disclosed
EP-3341482-A1 ARTIFICIAL NUCLEIC ACID MOLECULES CureVac AG (DE) 2018-07-04 — — EP disclosed
WO-2017036580-A1 ARTIFICIAL NUCLEIC ACID MOLECULES CUREVAC AG (DE) 2017-03-09 — — WO disclosed
EP-1446505-A4 PRE-EXISTING NUCLEIC ACIDS COVALENTLY ATTACHED TO A METAL SURFACE OR A METAL CLUSTER, INTERMEDIATES THEREOF AND METHODS OF USING SAME YEDA RES & DEV (IL) 2006-03-08 — — EP disclosed
US-20040248134-A1 Pre-existing nucleic acids covalently attached to a metal surface of a metal cluster, intermediates thereof and methods of using same YEDA RESEARCH AND DEVELOPMENT CO., LTD. (IL) 2004-12-09 — — US disclosed
EP-1446505-A2 PRE-EXISTING NUCLEIC ACIDS COVALENTLY ATTACHED TO A METAL SURFACE OR A METAL CLUSTER, INTERMEDIATES THEREOF AND METHODS OF USING SAME YEDA RESEARCH AND DEVELOPMENT CO., Ltd. (IL) 2004-08-18 — — EP disclosed
US-6605713-B1 Contacting D-nucleic acids with a racemic mixture of the target molecule and allow for binding; producing L-nucleic acids; in vitro selection of DNA/RNA with high binding affinity and stability FURSTE JENS PETER (DE) 2003-08-12 — — US disclosed
WO-2003038108-A2 PRE-EXISTING NUCLEIC ACIDS COVALENTLY ATTACHED TO A METAL SURFACE OR A METAL CLUSTER, INTERMEDIATES THEREOF AND METHODS OF USING SAME YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) 2003-05-08 — — WO disclosed
EP-0934331-B1 MIRROR-SYMMETRICAL SELECTION AND EVOLUTION OF NUCLEIC ACIDS FUERSTE JENS PETER (DE) 2002-11-27 — — EP disclosed
Send feedback